Mission statement · Company scope
“Lyell’s mission is to fully realize the curative potential of next-generation CAR T-cell therapies and meaningfully improve outcomes for patients with cancer.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Customer-centric (primary) · Innovation · Impact
- Leads with
- Audience
- Best for
- Climate & health · Service business
- Formula
- We help [who] [outcome] by [how]
- Tone
- Plain
- Length
- 22 words · reading grade 15.4
- Review status
- unreviewed · classifier rules-v0
- Quality score
- 0.70
- Record
- st_9cf150a8bba452d4
- Classification confidence
- 0.57
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-12 · sec_sentence · 10-K · accession 0001628280-26-017253
View filing ↗0 to compareCompare